Brifing

UAE Shifts Obesity Focus From Weight to Cardiometabolic Health

New national health data highlights obesity as a chronic disease requiring medical intervention.

The National2 min

1Redefining Obesity Metrics

The UAE is moving beyond simple scale readings to address obesity as a complex, chronic disease. According to the 2024-2025 National Health and Nutrition Survey, 22.4 percent of adults live with obesity. This shift prioritizes overall cardiometabolic health, recognizing that weight is often linked to serious conditions like diabetes and heart disease.

2Prevalence of Comorbidities

National survey data reveals that obesity rarely occurs in isolation among the UAE population. Over half of adults exhibit high cholesterol levels, while one in four suffers from high blood pressure. Additionally, one in eight individuals reports raised blood glucose, underscoring the urgent need for comprehensive medical management beyond weight loss.

3Combating Social Stigma

Medical experts emphasize that obesity is not merely a failure of personal willpower or discipline. This persistent stigma often prevents patients from seeking necessary professional care. By framing obesity as a chronic disease, health authorities aim to encourage earlier medical consultations and reduce the psychological barriers that hinder effective long-term health management.

4Scientific Breakthroughs in Treatment

Research into GLP-1 medicines has evolved significantly since 2017, moving from diabetes management to broader weight and cardiovascular care. Clinical trials demonstrate that these treatments help lower the risk of major events like strokes and heart attacks. This evidence shifts the focus from aesthetic weight loss to sustainable, long-term cardiovascular health outcomes.

5Regulatory Speed and Innovation

The UAE has established itself as a global leader in approving innovative medical treatments while maintaining rigorous safety standards. In June, the Emirates Drug Establishment approved a tablet form of GLP-1 for weight management. The UAE became the first country outside the United States to authorize this specific medication for its patients.

6Expanding Regional Infrastructure

Novo Gulf is deepening its commitment to the region by planning a new distribution center within the UAE. This facility will serve the Gulf and wider areas, reflecting the company's long-term strategy. The move aligns with the UAE's national ambition to prioritize chronic disease management through improved access to medical resources.

7Foundations of Patient Care

Despite medical advancements, diet and physical activity remain the fundamental pillars of obesity management. Professional guidance is essential to ensure that treatments are tailored to the whole person. Programs like NovoCare provide digital tools and patient educators to help individuals understand their condition and navigate their personal health journeys effectively.

8The Importance of Dialogue

The most critical step for patients is initiating an honest conversation with a healthcare provider as early as possible. Medical professionals can look past the scale to assess heart health, blood sugar, and pressure. By prioritizing early intervention, patients can better manage their chronic conditions and improve their overall quality of life.

Original article: The National — UAE Shifts Obesity Focus From Weight to Cardiometabolic Health